Assessment of Efficacy of Vardenafil, Influence on Self-esteem and Self-confidence in Subjects With Erectile Dysfunction

PHASE3CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions
Erectile Dysfunction
Interventions
DRUG

Levitra (Vardenafil, BAY38-9456)

5 mg, 10 mg and 20 mg one hour prior to sexual intercourse

DRUG

Placebo

Matching placebo

Trial Locations (13)

18003

Granada

28280

Hondarribia

28911

Leganés

28935

Móstoles

29010

Málaga

33006

Oviedo

36211

Vigo

41071

Seville

46014

Valencia

47011

Valladolid

03010

Alicante

08208

Sabadell

08025

Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY